Aditi Soni, MBA, PMP, currently serves as Vice President - Head of Program and Alliance Management at Kelonia Therapeutics and holds the role of Vice President at Saheli, Support and Friendship For South Asian Women and Families. Previously, Aditi was the Head of Program Management at Aurion Biotech, leading the development of a cell therapy for corneal endothelial disease and achieving significant milestones including NDA approval in Japan. Aditi has extensive experience in program and alliance management, demonstrated in previous roles at Dyne Therapeutics, Voyager Therapeutics, and Novartis Institutes for BioMedical Research. Aditi's educational background includes an Executive MBA from MIT Sloan School of Management and a Master of Science in Biotechnology from Panjab University.
August, 2024 - present